14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ARDS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Aridis Pharmaceuticals Inc. stock price on Monday moving between $0.0600 and $0.0669
(Updated on Apr 22, 2024)

Sell candidate since Apr 11, 2024 Loss -12.22% PDF

The Aridis Pharmaceuticals Inc. stock price gained 7.50% on the last trading day (Monday, 22nd Apr 2024), rising from $0.0600 to $0.0645. During the last trading day the stock fluctuated 11.50% from a day low at $0.0600 to a day high of $0.0669. The price has fallen in 7 of the last 10 days and is down by -5.15% for this period. Volume fell on the last day by -73 thousand shares and in total, 41 thousand shares were bought and sold for approximately $2.66 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.0600 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -2.77% during the next 3 months and, with a 90% probability hold a price between $0.0583 and $0.0807 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ARDS Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 7.50%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Aridis Pharmaceuticals Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0663 and $0.0735. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Aridis Pharmaceuticals Inc. stock

Aridis Pharmaceuticals Inc. finds support from accumulated volume at $0.0615 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0069 between high and low, or 11.50%. For the last week the stock has had daily average volatility of 10.69%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ARDS) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Aridis Pharmaceuticals Inc. to open at $0.0638, and during the day (based on 14 day Average True Range), to move between $0.0571 and $0.0719, which gives a possible trading interval of +/-$0.0074 (+/-11.54%) up or down from last closing price. If Aridis Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 23.09% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0615 (4.61%) than the resistance at $0.0680 (5.43%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Aridis Pharmaceuticals Inc. stock A Buy?

Aridis Pharmaceuticals Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -1.464 Sell Candidate Upgraded

Predicted Opening Price for Aridis Pharmaceuticals Inc. of Tuesday, April 23, 2024

Fair opening price April 23, 2024 Current price
$0.0638 ( 1.09%) $0.0645

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ARDS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0707 9.61 %
R2 0.0681 5.53 %
R1 0.0664 3.00 %
Current price: 0.0645
Support S1 0.0612 -5.17 %
S2 0.0595 -7.70 %
S3 0.0569 -11.78 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.0750 16.28 %
R2 0.0690 6.98 %
R1 0.0680 5.43 %
Current price 0.0645
Support S1 0.0615 -4.61%
S2 0.0600 -6.98%
S3 0 .

FAQ

What is the symbol for Aridis Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for Aridis Pharmaceuticals Inc. is ARDS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aridis Pharmaceuticals Inc. Stock?
Aridis Pharmaceuticals Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Aridis Pharmaceuticals Inc. Stock?
Aridis Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aridis Pharmaceuticals Inc. Stock.

What's the current price of Aridis Pharmaceuticals Inc. Stock?
As of the end of day on the Apr 22, 2024, the price of an Aridis Pharmaceuticals Inc. (ARDS) share was $0.0645.

What is the 52-week high and low for Aridis Pharmaceuticals Inc. Stock?
The 52-week high for Aridis Pharmaceuticals Inc. Stock is $0.540 and the 52-week low is $0.0500.

What is the market capitalization of Aridis Pharmaceuticals Inc. Stock?
As of the Apr 22, 2024, the market capitalization of Aridis Pharmaceuticals Inc. is 2.875M.

When is the next earnings date for Aridis Pharmaceuticals Inc.?
The upcoming earnings date for Aridis Pharmaceuticals Inc. is Jun 13, 2024.
Click to get the best stock tips daily for free!

About Aridis Pharmaceuticals Inc.

Aridis Pharmaceuticals. Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the treatment of lung infections resulting from S. aureus alphatoxin. The company is also developing AR-32... ARDS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT